SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-033177
Filing Date
2012-05-04
Accepted
2012-05-04 15:37:58
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-10029_110q.htm 10-Q 807935
2 EX-31.1 a12-10029_1ex31d1.htm EX-31.1 11507
3 EX-31.2 a12-10029_1ex31d2.htm EX-31.2 11473
4 EX-32.1 a12-10029_1ex32d1.htm EX-32.1 5940
5 EX-32.2 a12-10029_1ex32d2.htm EX-32.2 5753
  Complete submission text file 0001104659-12-033177.txt   3334369

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anth-20120331.xml EX-101.INS 352007
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anth-20120331.xsd EX-101.SCH 34755
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anth-20120331_cal.xml EX-101.CAL 36222
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anth-20120331_lab.xml EX-101.LAB 469682
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anth-20120331_pre.xml EX-101.PRE 186139
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anth-20120331_def.xml EX-101.DEF 132996
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 12814079
SIC: 2834 Pharmaceutical Preparations